BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2022 8:30:45 AM | Browse: 683 | Download: 2226
 |
Received |
|
2022-06-06 00:51 |
|
Peer-Review Started |
|
2022-06-06 00:53 |
|
First Decision by Editorial Office Director |
|
2022-08-07 18:05 |
|
Return for Revision |
|
2022-08-07 18:05 |
|
Revised |
|
2022-08-19 05:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-09-06 03:20 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-09-07 23:42 |
|
Articles in Press |
|
2022-09-07 23:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-10-09 03:33 |
|
Publish the Manuscript Online |
|
2022-10-14 08:30 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-Fen Lian, Dong-Hui Lu, Hong-Li Liu, Yan-Jing Liu, Xiu-Qun Han, Yang Yang, Yuan Lin, Qing-Xiang Zeng, Zheng-Jie Huang, Feng Xie, Cai-Hao Huang, Hong-Mei Wu, Ai-Mei Long, Li-Ping Deng and Fan Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shenzhen Science and Technology Innovation Committee Projects |
JCYJ20170816105416349 |
| Shenzhen High-level Hospital Construction Fund |
|
| Shenzhen Key Medical Discipline Construction Fund |
SZXK010 |
|
| Corresponding Author |
Fan Zhang, MD, Doctor, Doctor, Department of Endocrinology, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Futian District, Shenzhen 518000, Guangdong Province, China. bjdxszyynfm@163.com |
| Key Words |
Type 2 diabetes; Human umbilical cord mesenchymal stem cells; Blood glucose; Homeostasis model assessment of β-cell function; Hypoglycemic agents |
| Core Tip |
Our article focused on the effectiveness and safety of human umbilical cord mesenchymal stem cell (hUC-MSC) infusion for treating type 2 diabetes. The results suggest that hUC-MSC infusion can improve glycemia, restore islet β‑cell function, and reduce the dosage of hypoglycemic agents without serious adverse events. |
| Publish Date |
2022-10-14 08:30 |
| Citation |
Lian XF, Lu DH, Liu HL, Liu YJ, Han XQ, Yang Y, Lin Y, Zeng QX, Huang ZJ, Xie F, Huang CH, Wu HM, Long AM, Zhang F. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus. World J Diabetes 2022; 13(10): 877-887
|
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i10/877.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i10.877 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
